Amphastar Capital Surpluse vs Deferred Long Term Liab Analysis

AMPH Stock

USD 42.22 2.28 5.12%

Amphastar financial indicator trend analysis is way more than just evaluating Amphastar P prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Amphastar P is a good investment. Please check the relationship between Amphastar Capital Surpluse and its Deferred Long Term Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amphastar P. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

Capital Surpluse vs Deferred Long Term Liab

Capital Surpluse vs Deferred Long Term Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Amphastar P Capital Surpluse account and Deferred Long Term Liab. At this time, the significance of the direction appears to have pay attention.

The correlation between Amphastar's Capital Surpluse and Deferred Long Term Liab is -0.8. Overlapping area represents the amount of variation of Capital Surpluse that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of Amphastar P, assuming nothing else is changed. The correlation between historical values of Amphastar's Capital Surpluse and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Surpluse of Amphastar P are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Capital Surpluse i.e., Amphastar's Capital Surpluse and Deferred Long Term Liab go up and down completely randomly.

Correlation Coefficient

-0.8

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Capital Surpluse

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Most indicators from Amphastar's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Amphastar P current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amphastar P. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

As of now, Amphastar's Tax Provision is increasing as compared to previous years. The Amphastar's current Enterprise Value Over EBITDA is estimated to increase to 21.26, while Selling General Administrative is projected to decrease to under 46.2 M.

	2021	2022	2023	2024 (projected)
Interest Expense	885K	1.8M	27.2M	28.5M
Depreciation And Amortization	26.8M	28.7M	41.8M	43.9M

Interest Expense Depreciation And Amortization

Amphastar fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity
Common Stock Shares Outstanding		0.42	0.27	0.36	0.37	0.66	0.54	0.72	-0.17	0.18	0.38	0.24	0.62	0.4	0.56	0.79	0.27	0.46	0.48	0.83	0.7	0.27	0.29	0.67	0.55	0.83
Total Assets	0.42		0.97	0.96	0.98	0.78	0.86	0.68	0.12	0.93	0.97	0.12	0.67	0.99	0.91	0.62	0.96	0.98	0.72	0.31	0.74	0.98	0.98	0.62	0.54	0.43
Short Long Term Debt Total	0.27	0.97		0.96	0.96	0.64	0.73	0.51	0.15	0.99	0.93	0.03	0.52	0.98	0.83	0.45	1.0	0.92	0.61	0.17	0.61	1.0	1.0	0.45	0.36	0.23
Other Current Liab	0.36	0.96	0.96		0.96	0.7	0.78	0.58	0.04	0.93	0.92	0.0	0.61	0.97	0.84	0.57	0.96	0.94	0.67	0.29	0.69	0.96	0.96	0.46	0.43	0.37
Total Current Liabilities	0.37	0.98	0.96	0.96		0.72	0.83	0.66	0.06	0.93	0.93	0.2	0.61	0.99	0.86	0.57	0.96	0.95	0.7	0.27	0.68	0.97	0.97	0.56	0.47	0.4
Total Stockholder Equity	0.66	0.78	0.64	0.7	0.72		0.87	0.92	0.06	0.55	0.81	0.13	0.94	0.73	0.86	0.9	0.63	0.83	0.93	0.47	0.96	0.66	0.67	0.82	0.84	0.61
Other Liab	0.54	0.86	0.73	0.78	0.83	0.87		0.89	0.07	0.63	0.88	0.18	0.86	0.81	0.9	0.75	0.71	0.9	0.87	0.35	0.84	0.74	0.75	0.75	0.81	0.62
Property Plant And Equipment Net	0.72	0.68	0.51	0.58	0.66	0.92	0.89		-0.05	0.41	0.67	0.35	0.86	0.64	0.76	0.9	0.49	0.72	0.85	0.57	0.88	0.53	0.53	0.87	0.84	0.78
Current Deferred Revenue	-0.17	0.12	0.15	0.04	0.06	0.06	0.07	-0.05		0.15	0.2	-0.44	0.08	0.09	0.02	-0.18	0.14	0.14	0.03	-0.28	-0.06	0.16	0.15	0.28	-0.04	-0.27
Net Debt	0.18	0.93	0.99	0.93	0.93	0.55	0.63	0.41	0.15		0.87	0.02	0.39	0.95	0.74	0.35	0.99	0.85	0.52	0.11	0.52	0.98	0.98	0.36	0.25	0.14
Retained Earnings	0.38	0.97	0.93	0.92	0.93	0.81	0.88	0.67	0.2	0.87		0.02	0.75	0.95	0.94	0.6	0.92	0.99	0.77	0.21	0.76	0.94	0.94	0.63	0.64	0.36
Accounts Payable	0.24	0.12	0.03	0.0	0.2	0.13	0.18	0.35	-0.44	0.02	0.02		0.08	0.12	0.18	0.25	0.02	0.08	0.11	0.24	0.14	0.05	0.03	0.28	0.11	0.38
Cash	0.62	0.67	0.52	0.61	0.61	0.94	0.86	0.86	0.08	0.39	0.75	0.08		0.6	0.83	0.83	0.5	0.79	0.91	0.42	0.91	0.53	0.54	0.76	0.85	0.59
Non Current Assets Total	0.4	0.99	0.98	0.97	0.99	0.73	0.81	0.64	0.09	0.95	0.95	0.12	0.6		0.88	0.59	0.98	0.95	0.67	0.3	0.71	0.99	0.99	0.57	0.47	0.4
Non Currrent Assets Other	0.56	0.91	0.83	0.84	0.86	0.86	0.9	0.76	0.02	0.74	0.94	0.18	0.83	0.88		0.74	0.82	0.95	0.78	0.41	0.87	0.83	0.85	0.7	0.69	0.57
Other Assets	0.79	0.62	0.45	0.57	0.57	0.9	0.75	0.9	-0.18	0.35	0.6	0.25	0.83	0.59	0.74		0.45	0.67	0.76	0.68	0.91	0.47	0.48	0.78	0.78	0.83
Long Term Debt	0.27	0.96	1.0	0.96	0.96	0.63	0.71	0.49	0.14	0.99	0.92	0.02	0.5	0.98	0.82	0.45		0.91	0.59	0.19	0.61	1.0	1.0	0.44	0.34	0.23
Cash And Short Term Investments	0.46	0.98	0.92	0.94	0.95	0.83	0.9	0.72	0.14	0.85	0.99	0.08	0.79	0.95	0.95	0.67	0.91		0.79	0.32	0.8	0.93	0.93	0.66	0.64	0.46
Net Receivables	0.48	0.72	0.61	0.67	0.7	0.93	0.87	0.85	0.03	0.52	0.77	0.11	0.91	0.67	0.78	0.76	0.59	0.79		0.21	0.88	0.63	0.63	0.63	0.81	0.42
Good Will	0.83	0.31	0.17	0.29	0.27	0.47	0.35	0.57	-0.28	0.11	0.21	0.24	0.42	0.3	0.41	0.68	0.19	0.32	0.21		0.52	0.17	0.2	0.59	0.37	0.88
Common Stock Total Equity	0.7	0.74	0.61	0.69	0.68	0.96	0.84	0.88	-0.06	0.52	0.76	0.14	0.91	0.71	0.87	0.91	0.61	0.8	0.88	0.52		0.62	0.64	0.74	0.76	0.67
Short Term Investments	0.27	0.98	1.0	0.96	0.97	0.66	0.74	0.53	0.16	0.98	0.94	0.05	0.53	0.99	0.83	0.47	1.0	0.93	0.63	0.17	0.62		1.0	0.48	0.4	0.25
Non Current Liabilities Total	0.29	0.98	1.0	0.96	0.97	0.67	0.75	0.53	0.15	0.98	0.94	0.03	0.54	0.99	0.85	0.48	1.0	0.93	0.63	0.2	0.64	1.0		0.48	0.39	0.26
Inventory	0.67	0.62	0.45	0.46	0.56	0.82	0.75	0.87	0.28	0.36	0.63	0.28	0.76	0.57	0.7	0.78	0.44	0.66	0.63	0.59	0.74	0.48	0.48		0.74	0.72
Other Current Assets	0.55	0.54	0.36	0.43	0.47	0.84	0.81	0.84	-0.04	0.25	0.64	0.11	0.85	0.47	0.69	0.78	0.34	0.64	0.81	0.37	0.76	0.4	0.39	0.74		0.6
Other Stockholder Equity	0.83	0.43	0.23	0.37	0.4	0.61	0.62	0.78	-0.27	0.14	0.36	0.38	0.59	0.4	0.57	0.83	0.23	0.46	0.42	0.88	0.67	0.25	0.26	0.72	0.6

Click cells to compare fundamentals

Amphastar Account Relationship Matchups

Amphastar fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	49.9M	49.1M	49.8M	52.4M	53.0M	42.9M
Total Assets	587.0M	631.2M	671.5M	742.0M	1.5B	1.6B
Short Long Term Debt Total	66.6M	67.3M	104.7M	102.6M	623.6M	654.8M
Other Current Liab	2.0M	67.8M	64.3M	60.7M	190.1M	199.6M
Total Current Liabilities	90.0M	112.2M	103.8M	94.9M	225.4M	236.7M
Total Stockholder Equity	381.4M	402.3M	445.5M	528.7M	639.4M	408.7M
Other Liab	13.7M	18.7M	22.7M	21.9M	25.2M	26.5M
Property Plant And Equipment Net	253.5M	280.7M	271.5M	264.6M	315.6M	223.6M
Net Debt	(7.1M)	(25.4M)	(21.7M)	(53.5M)	479.3M	503.3M
Retained Earnings	116.4M	117.8M	180.3M	271.7M	409.3M	429.7M
Accounts Payable	77.1M	24.4M	22.2M	20.5M	25.4M	32.3M
Cash	73.7M	92.6M	126.4M	156.1M	144.3M	96.7M
Non Current Assets Total	331.7M	351.6M	353.4M	363.7M	1.0B	1.1B
Non Currrent Assets Other	11.2M	5.3M	16.7M	20.9M	25.9M	27.2M
Other Assets	37.0M	50.9M	39.1M	59.4M	68.3M	35.9M
Long Term Debt	39.4M	34.2M	74.8M	72.8M	589.6M	619.1M
Cash And Short Term Investments	85.4M	105.6M	136.7M	175.8M	256.8M	269.6M
Net Receivables	45.7M	66.0M	78.8M	88.8M	114.9M	58.4M
Good Will	3.6M	3.9M	3.3M	3.1M	3.2M	3.5M
Short Term Investments	11.7M	13.0M	10.3M	19.7M	112.5M	118.1M
Liabilities And Stockholders Equity	587.0M	631.2M	671.5M	742.0M	1.5B	1.6B
Non Current Liabilities Total	69.4M	70.3M	122.2M	118.5M	648.1M	680.5M
Inventory	110.5M	96.8M	92.8M	103.6M	105.8M	91.3M
Other Current Assets	9.5M	11.2M	9.8M	17.7M	12.0M	8.8M
Other Stockholder Equity	269.7M	288.2M	271.9M	265.6M	238.6M	269.2M
Total Liab	159.4M	182.5M	226.0M	213.3M	873.5M	917.2M
Property Plant And Equipment Gross	233.9M	280.7M	271.5M	264.6M	560.9M	589.0M
Total Current Assets	255.2M	279.7M	318.1M	378.3M	489.6M	277.4M
Accumulated Other Comprehensive Income	(4.7M)	(3.7M)	(6.8M)	(8.6M)	(8.5M)	(8.9M)
Short Term Debt	10.9M	19.0M	8.2M	9.1M	8.2M	9.9M
Intangible Assets	37.5M	36.7M	35.6M	34.2M	610.1M	640.6M
Property Plant Equipment	233.9M	260.1M	244.2M	238.3M	274.0M	203.0M
Net Tangible Assets	340.2M	361.7M	406.7M	491.4M	565.1M	361.3M
Retained Earnings Total Equity	116.4M	117.8M	180.3M	271.7M	312.5M	328.1M
Long Term Debt Total	39.4M	34.2M	74.8M	72.8M	83.8M	48.0M
Capital Surpluse	367.3M	410.1M	422.4M	455.1M	523.3M	374.6M

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

When determining whether Amphastar P offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amphastar's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amphastar P Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amphastar P Stock:

How To Invest In Amphastar

Details

Is Amphastar Stock a good investment?

Details

What is Amphastar's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amphastar P. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amphastar. If investors know Amphastar will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amphastar listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.14)

Earnings Share

3.01

Revenue Per Share

14.942

Quarterly Revenue Growth

0.059

Return On Assets

0.0867

The market value of Amphastar P is measured differently than its book value, which is the value of Amphastar that is recorded on the company's balance sheet. Investors also form their own opinion of Amphastar's value that differs from its market value or its book value, called intrinsic value, which is Amphastar's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amphastar's market value can be influenced by many factors that don't directly affect Amphastar's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Amphastar's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amphastar is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amphastar's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Amphastar Capital Surpluse vs Deferred Long Term Liab Analysis

Capital Surpluse vs Deferred Long Term Liab

Capital Surpluse vs Deferred Long Term Liab Correlation Analysis

Correlation Coefficient

Capital Surpluse

Deferred Long Term Liab

Amphastar fundamental ratios Correlations

Amphastar Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Amphastar fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Long Term Debt	+ 1.0	Short Long Term Debt Total
Short Term Investments	+ 1.0	Short Long Term Debt Total
Non Current Liabilities Total	+ 1.0	Short Long Term Debt Total
Short Term Investments	+ 1.0	Long Term Debt
Non Current Liabilities Total	+ 1.0	Long Term Debt
Non Current Liabilities Total	+ 1.0	Short Term Investments

Accounts Payable	- 0.44	Current Deferred Revenue
Good Will	- 0.28	Current Deferred Revenue
Other Stockholder Equity	- 0.27	Current Deferred Revenue
Other Assets	- 0.18	Current Deferred Revenue
Current Deferred Revenue	- 0.17	Common Stock Shares Outstanding
Common Stock Total Equity	- 0.06	Current Deferred Revenue